Found 9 matching trials
Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
PHASE3To evaluate the efficacy of KHK7580 orally administered up to 24 weeks for ...
Location
Osaka City University Hospital
Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers
PHASE1The primary objective is to evaluate the pharmacokinetic profile of KHK7580...
Phase 2 Study of KHK7580
PHASE2This randomized, placebo-controlled, double-blind (included open arm of KRN...
Location
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin
Phase 3 Study of KHK7580
PHASE2The purpose of this study is to evaluate the efficacy and safety of KHK7580...
Location
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin
Phase 3 Study of KHK7580
PHASE3This study is designed to evaluate efficacy and safety of KHK7580 orally ad...
Location
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin
Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis
PHASE1This study is designed to evaluate safety, pharmacokinetics and pharmacodyn...
Location
Kyowa Hakko Kirin
Phase 3 Study of KHK7580
PHASE3This long-term study is designed to evaluate safety and efficacy of KHK7580...
Location
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin
Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia
PHASE3The purpose of this study is to evaluate the efficacy and the safety of KHK...
Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
PHASE1This study is designed to evaluate safety, pharmacokinetics and pharmacodyn...
Location
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin